Article Details

Dermtreat Announces First Patient Dosed in Phase 2b Clinical Trial of Rivelin Clobetasol for Oral ...

Retrieved on: 2018-07-22 21:16:27

Tags for this article:

Click the tags to see associated articles and topics

Dermtreat Announces First Patient Dosed in Phase 2b Clinical Trial of Rivelin Clobetasol for Oral .... View article details on hiswai:

Excerpt

<div>Investors include <b>Sofinnova Ventures</b>, Lundbeckfonden Emerge, Novo Seeds and Welfare Tech Invest. For additional information, please visit ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo